Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025)
Aurora Cannabis (ACB) posted quarterly Cash from Investing Activities of -$979864.6 for Q1 2025, up 67.9% year-over-year from -$583608.4 in Q1 2024, and up 57.38% quarter-over-quarter from -$2.3 million in Q4 2024.
Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Cash from Investing Activities for 9 consecutive years, with -$979864.6 the latest figure, recorded in Q1 2025.
- In Q1 2025, Cash from Investing Activities rose 67.9% year-over-year to -$979864.6; the TTM figure through Mar 2025 stood at -$6.0 million (up 88.19% YoY), while the FY2026 annual figure was -$53.1 million, down 522.19% from the prior year.
- Cash from Investing Activities rose to -$979864.6 in Q1 2025 per ACB's latest filing, from -$2.3 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $25.8 million in Q4 2021 and bottomed at -$62.6 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$10.0 million across 5 years, with a median of -$2.7 million in 2024.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities jumped 770.37% — and 2022, when it sank 324.38%.
- Aurora Cannabis' Cash from Investing Activities stood at $25.8 million in 2021, then slumped by 291.45% to -$49.5 million in 2022, then soared by 110.22% to $5.1 million in 2023, then plunged by 145.45% to -$2.3 million in 2024, then surged by 57.38% to -$979864.6 in 2025.
- Business Quant data shows ACB's Cash from Investing Activities at -$979864.6 in Q1 2025, -$2.3 million in Q4 2024, and -$2.7 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aurora Cannabis | 243.01 Mn | 170.70 Mn | 25.75 Mn | 895,704.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -979,864.57 |
| Mar 31, 2025 | -979,864.57 |
| Dec 31, 2024 | -2.30 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | -2.67 Mn |
| Sep 30, 2024 | -2.67 Mn |
| Jun 30, 2024 | -11,698.25 |
| Jun 30, 2024 | -11,698.25 |
| Mar 31, 2024 | -3.05 Mn |
| Mar 31, 2024 | -3.05 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Sep 30, 2023 | -2.97 Mn |
| Sep 30, 2023 | -2.97 Mn |
| Dec 31, 2022 | -49.48 Mn |
| Dec 31, 2022 | -49.48 Mn |
| Sep 30, 2022 | -62.62 Mn |
| Sep 30, 2022 | -62.62 Mn |
| Jun 30, 2022 | -31.17 Mn |
| Jun 30, 2022 | -31.17 Mn |